Inter Parfums (IPAR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record third quarter net sales of $424.6M–$425M, up 15–15.4% year-over-year, and nine-month sales of $1.09B, up 10.3–10% year-over-year, driven by robust fragrance demand and new brands Lacoste and Roberto Cavalli.
Net income attributable to Interparfums rose 17% to $62.3M–$62M for Q3 2024; diluted EPS increased 16% to $1.93–$1.94.
Strongest sales growth in Western Europe (+25%), Asia/Pacific (+15%), and North America (+12%), with double-digit increases in all major markets.
Strategic focus on digital marketing, influencer partnerships, and new product launches contributed to performance.
European operations contributed 67% of net sales; US operations 33%.
Financial highlights
Gross margin for Q3 2024 was 63.9%, unchanged year-over-year; nine-month gross margin at 63.6%.
Operating margin for Q3 was 25.0%, up from 23.7% last year; nine-month operating margin at 21.9%.
SG&A expenses increased 12% in Q3, below sales growth, improving efficiency.
Net income impacted by $3.3M–$4M FX losses in Q3, compared to gains last year.
Cash, cash equivalents, and short-term investments totaled $157M at quarter-end; working capital at $617M.
Outlook and guidance
2024 guidance reaffirmed: net sales of $1.45B and EPS of $5.15, with upper single-digit Q4 growth expected.
Full-year gross margin expected to be slightly ahead of 2023 at approximately 64%.
Management expects a strong Q4 and record full-year results, with more moderate growth in 2025.
Destocking trend is slowing and largely behind, with retailers well-stocked for the holiday season.
Initial 2025 guidance to be announced November 12, 2024.
Latest events from Inter Parfums
- Voting standards for Proposal 3 and other matters clarified; majority approval required.IPAR
Proxy filing - Sustained growth, strong brand launches, and robust shareholder returns define recent performance.IPAR
Investor presentation - Key votes on directors, executive pay, and stock plan extension are set, with board support.IPAR
Proxy filing - Net sales grew 2% to $685.9M, with margin gains and strong U.S. and brand performance.IPAR
Q2 2026 - Q1 2026 net sales up 2% to $345M, gross margin 65.1%, net income $43.4M, guidance reaffirmed.IPAR
Q1 2026 - Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 2025 - Record Q2 sales and margin gains, strong new launches, and 2024 guidance reaffirmed.IPAR
Q2 2024 - Q1 2025 net sales up 5%, net income $42.5M, margins and guidance strong, key licenses renewed.IPAR
Q1 2025 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 2024